A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02497378 · COMPLETED
Trial details
- NCT number
- NCT02497378
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-10
- Primary completion
- 2018-03-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.